|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.00 IDR | +1.54% |
|
+5.88% | -11.61% |
| Market Cap | 334B 18.62M 16.11M 15.04M 13.8M 25.96M 1.77B 26.37M 176M 69.27M 888M 69.93M 68.4M 2.94B | P/E 2024 |
82x | P/E 2025 | -13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 457B 25.54M 22.09M 20.63M 18.93M 35.6M 2.43B 36.16M 242M 95M 1.22B 95.91M 93.81M 4.03B | EV / Sales 2024 |
1.35x | EV / Sales 2025 | 1.38x |
| Free-Float |
20% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.54% | ||
| 1 week | +5.88% | ||
| Current month | +5.88% | ||
| 1 month | +10.61% | ||
| 3 months | -0.50% | ||
| 6 months | -22.05% | ||
| Current year | -11.61% |
| 1 week | 180 |  | 208 |
| 1 month | 174 | | 220 |
| Current year | 167 | | 340 |
| 1 year | 167 | | 340 |
| 3 years | 164 | | 340 |
| 5 years | 164 | | 340 |
| 10 years | 164 | | 340 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kartono Gunawa
CEO | Chief Executive Officer | 58 | 21/06/2023 |
Handri Sutanto
AUD | Comptroller/Controller/Auditor | 46 | 28/06/2023 |
| Corporate Officer/Principal | 53 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 85 | 18/05/1978 | |
Titianus Winata
BRD | Director/Board Member | 90 | 01/01/2016 |
Susanto Lam
BRD | Director/Board Member | 58 | 21/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.54% | +5.88% | +2.06% | - | 18.62M | |
| -0.52% | +3.21% | +89.52% | +125.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.79% | 625B | |
| +0.89% | -1.95% | +24.23% | +63.19% | 435B | |
| +0.71% | +3.87% | +49.07% | +38.29% | 363B | |
| +0.64% | -0.49% | +33.94% | +38.94% | 296B | |
| +0.39% | -5.83% | +8.92% | +6.39% | 249B | |
| +1.51% | +6.69% | +42.58% | +58.47% | 222B | |
| +3.92% | -0.46% | -5.56% | -51.70% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.16% | 165B | |
| Average | +1.18% | +1.61% | +30.59% | +43.87% | 362.08B | |
| Weighted average by Cap. | +0.66% | +1.33% | +48.72% | +63.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 412B 23.01M 19.9M 18.58M 17.05M 32.06M 2.19B 32.57M 218M 85.57M 1.1B 86.39M 84.5M 3.63B | 364B 20.3M 17.56M 16.4M 15.04M 28.29M 1.93B 28.74M 192M 75.5M 968M 76.22M 74.55M 3.2B |
| Net income | 5.01B 280K 242K 226K 207K 390K 26.65M 396K 2.65M 1.04M 13.36M 1.05M 1.03M 44.15M | -28.78B -1.61M -1.39M -1.3M -1.19M -2.24M -153M -2.28M -15.23M -5.98M -76.66M -6.03M -5.9M -253M |
| Net Debt | 147B 8.22M 7.11M 6.64M 6.09M 11.45M 782M 11.63M 77.86M 30.56M 392M 30.85M 30.18M 1.3B | 124B 6.92M 5.98M 5.59M 5.13M 9.64M 658M 9.79M 65.56M 25.73M 330M 25.98M 25.41M 1.09B |
Employees
1,031
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | IDR 198.00 | +1.54% | 78,400 |
| 06/08/26 | IDR 195.00 | +2.63% | 440,400 |
| 05/08/26 | IDR 190.00 | -1.04% | 36,800 |
| 04/08/26 | IDR 192.00 | +4.35% | 88,800 |
| 03/08/26 | IDR 184.00 | -1.60% | 42,400 |
- Stock Market
- Stocks
- IKPM Stock
Select your edition
All financial news and data tailored to specific country editions
